November 9th 2024
Evolving industry demands are driving the need for greater flexibility and innovation in processing equipment for pharmaceutical manufacturing.
Lilly to Invest $72 Million for Insulin Manufacturing Upgrade
October 23rd 2017The $72-million investment, part of a larger $850-million investment into its US operations, will allow the drugmaker to replace an outdated insulin vial-filling line and to upgrade technology at its Indianapolis manufacturing plant.
A Glance of Merck Millipore’s New Solutions for Increased Efficiency
June 8th 2015Products on display include the newest addition to the Mobius line of single-use bioreactors; Cellvento CHO cell culture media for optimized production of specific cell lines; and new high-volume AFS water purification systems.
The Shape of Biopharmaceutical Facilities to Come
March 18th 2009The spotlight on the biopharmaceutical industry is intensifying, as recently evidenced by Pfizer's (New York) ongoing acquisition of Wyeth (Madison, NJ), which was initiated partly to reduce the former's dependence on small-molecule drugs.